Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Anticholinergic drug use and risk for dementia: target for dementia prevention.

Jessen F, Kaduszkiewicz H, Daerr M, Bickel H, Pentzek M, Riedel-Heller S, Wagner M, Weyerer S, Wiese B, van den Bussche H, Broich K, Maier W.

Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2:S111-5. doi: 10.1007/s00406-010-0156-4. Epub 2010 Oct 20.

PMID:
20960005
2.

Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.

Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Crane PK, Larson EB.

JAMA Intern Med. 2015 Mar;175(3):401-7. doi: 10.1001/jamainternmed.2014.7663.

3.

Drug-induced cognitive impairment in the elderly.

Moore AR, O'Keeffe ST.

Drugs Aging. 1999 Jul;15(1):15-28. Review.

PMID:
10459729
4.

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

Carrière I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, Ancelin ML.

Arch Intern Med. 2009 Jul 27;169(14):1317-24. doi: 10.1001/archinternmed.2009.229.

5.

Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia.

Kalisch Ellett LM, Pratt NL, Ramsay EN, Barratt JD, Roughead EE.

J Am Geriatr Soc. 2014 Oct;62(10):1916-22. doi: 10.1111/jgs.13054. Epub 2014 Oct 3.

PMID:
25284144
6.

[Drugs Effect on Cognition in the Elderly].

Brefel-Courbon C.

Therapie. 2015 Nov-Dec;70(6):523-6. doi: 10.2515/therapie/2015038. Epub 2015 Jul 28. Review. French.

PMID:
26220919
7.

Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.

Lee EK, Lee YJ.

Int J Clin Pharm. 2013 Oct;35(5):711-8. doi: 10.1007/s11096-013-9793-9. Epub 2013 May 25.

PMID:
23708883
8.

Risk of dementia in elderly patients with the use of proton pump inhibitors.

Haenisch B, von Holt K, Wiese B, Prokein J, Lange C, Ernst A, Brettschneider C, König HH, Werle J, Weyerer S, Luppa M, Riedel-Heller SG, Fuchs A, Pentzek M, Weeg D, Bickel H, Broich K, Jessen F, Maier W, Scherer M.

Eur Arch Psychiatry Clin Neurosci. 2015 Aug;265(5):419-28. doi: 10.1007/s00406-014-0554-0. Epub 2014 Oct 24.

PMID:
25341874
9.

Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia.

Whalley LJ, Sharma S, Fox HC, Murray AD, Staff RT, Duthie AC, Deary IJ, Starr JM.

J Alzheimers Dis. 2012;30(2):253-61. doi: 10.3233/JAD-2012-110935.

PMID:
22426015
10.

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.

Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K.

BMJ. 2006 Feb 25;332(7539):455-9. Epub 2006 Feb 1.

11.

Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.

Bhattacharya R, Chatterjee S, Carnahan RM, Aparasu RR.

Am J Geriatr Pharmacother. 2011 Dec;9(6):434-41. doi: 10.1016/j.amjopharm.2011.10.001. Epub 2011 Oct 26.

PMID:
22030114
12.

Long-term anticholinergic use and the aging brain.

Cai X, Campbell N, Khan B, Callahan C, Boustani M.

Alzheimers Dement. 2013 Jul;9(4):377-85. doi: 10.1016/j.jalz.2012.02.005. Epub 2012 Nov 22.

13.

Cholinesterase inhibitors and anticholinergic drugs: is the pharmacologic antagonism myth or reality?

Beier MT.

J Am Med Dir Assoc. 2005 Nov-Dec;6(6):413-4. No abstract available.

PMID:
16286067
14.

Potentially inappropriate anticholinergic medication use in older adults with dementia.

Kachru N, Carnahan RM, Johnson ML, Aparasu RR.

J Am Pharm Assoc (2003). 2015 Nov-Dec;55(6):603-12. doi: 10.1331/JAPhA.2015.14288.

PMID:
26501745
15.

Age of major depression onset, depressive symptoms, and risk for subsequent dementia: results of the German study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).

Heser K, Tebarth F, Wiese B, Eisele M, Bickel H, Köhler M, Mösch E, Weyerer S, Werle J, König HH, Leicht H, Pentzek M, Fuchs A, Riedel-Heller SG, Luppa M, Prokein J, Scherer M, Maier W, Wagner M; Age CoDe Study Group.

Psychol Med. 2013 Aug;43(8):1597-610. doi: 10.1017/S0033291712002449. Epub 2012 Nov 9.

PMID:
23137390
16.

The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study.

Fox C, Livingston G, Maidment ID, Coulton S, Smithard DG, Boustani M, Katona C.

Age Ageing. 2011 Nov;40(6):730-5. doi: 10.1093/ageing/afr102. Epub 2011 Sep 18.

PMID:
21926432
17.

[Effect of anticholinergic drugs on cognitive impairment in the elderly].

López-Álvarez J, Zea Sevilla MA, Agüera Ortiz L, Fernández Blázquez MÁ, Valentí Soler M, Martínez-Martín P.

Rev Psiquiatr Salud Ment. 2015 Jan-Mar;8(1):35-43. doi: 10.1016/j.rpsm.2013.11.003. Epub 2014 Jul 30. Review. Spanish.

18.

Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus.

Yang YW, Liu HH, Lin TH, Chuang HY, Hsieh T.

PLoS One. 2017 Apr 6;12(4):e0175335. doi: 10.1371/journal.pone.0175335. eCollection 2017.

19.

Dementia: anticholinergic medications might increase the risk of AD.

Chase A.

Nat Rev Neurol. 2015 Mar;11(3):125. doi: 10.1038/nrneurol.2015.11. Epub 2015 Feb 10. No abstract available.

PMID:
25666746
20.

Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.

Chatterjee S, Mehta S, Sherer JT, Aparasu RR.

Drugs Aging. 2010 Dec 1;27(12):987-97. doi: 10.2165/11584430-000000000-00000.

PMID:
21087068

Supplemental Content

Support Center